» Articles » PMID: 18218667

Rheumatoid Arthritis is Milder in the New Millennium: Health Status in Patients with Rheumatoid Arthritis 1994-2004

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2008 Jan 26
PMID 18218667
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: During the last decades major advances have occurred in the treatment of patients with rheumatoid arthritis (RA), and improvements in the burden of the disease have been suggested. We examined whether there was a secular change towards less severe disease from 1994 to 2004 among patients within the representative setting of the Oslo Rheumatoid Arthritis Register (ORAR).

Methods: All living patients in the ORAR received a postal questionnaire in 1994, 1996, 2001 and 2004, including the Modified Health Assessment Questionnaire (MHAQ), SF-36, Arthritis Impact Measurement Scales 2 (AIMS2) and visual analogue scales for the patient global assessment of disease severity, pain and fatigue. A mixed model approach was used for longitudinal analysis adjusting for sex, age, co-morbidity, and for disease duration and DMARD if indicated.

Results: The numbers of respondents aged between 20 and 79 years in 1994, 1996, 2001 and 2004 were 931, 1025, 829 and 914 patients with similar demographic characteristics (mean age in 1994 was 60.6 years, mean disease duration 12.6 years, 78% females). Health status in the population with RA was consistently improved in all dimensions of health, and this improvement was statistically significant for the physical dimension, global health and pain over the 10-year period until 2004. Both year of examination and year of disease onset had an effect on measures of longitudinal health status outcome.

Conclusions: Health status in RA improved from 1994 to 2004, probably due to access to better and more aggressive treatments.

Citing Articles

Comprehensive relationship between disease activity indices, mTSS, and mHAQ and physical function evaluation and QOL in females with rheumatoid arthritis.

Nagafusa T, Mizushima T, Suzuki M, Yamauchi K Sci Rep. 2023; 13(1):21905.

PMID: 38081947 PMC: 10713608. DOI: 10.1038/s41598-023-49380-y.


Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD).

Pisaniello H, Lester S, Russell O, Black R, Tieu J, Richards B RMD Open. 2023; 9(3).

PMID: 37507204 PMC: 10391633. DOI: 10.1136/rmdopen-2022-002962.


Experiences of group-based cognitive behavioural therapy for insomnia among patients with rheumatoid arthritis: a qualitative study.

Latocha K, Loppenthin K, Jennum P, Christensen R, Ostergaard M, Esbensen B BMJ Open. 2023; 13(1):e066221.

PMID: 36596631 DOI: 10.1136/bmjopen-2022-066221.


Joint Surgery in Tunisian Rheumatoid Arthritis Patients: Prevalence and Risk Factors.

Saidane O, Gafsi L, Ben Tekaya A, Mahmoud I, Tekaya R, Abdelmoula L Arch Rheumatol. 2021; 35(3):426-434.

PMID: 33458667 PMC: 7788662. DOI: 10.46497/ArchRheumatol.2020.7483.


Cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: protocol for the randomised, single-blinded, parallel-group Sleep-RA trial.

Latocha K, Loppenthin K, Ostergaard M, Jennum P, Christensen R, Hetland M Trials. 2020; 21(1):440.

PMID: 32471477 PMC: 7257190. DOI: 10.1186/s13063-020-04282-6.